TY - STD TI - World Health Organization (WHO). Cardiovascular diseases (CVDs) fact sheet. http://www.who.int/mediacentre/factsheets/fs317/en. Accessed 22 Jul 2017. UR - http://www.who.int/mediacentre/factsheets/fs317/en ID - ref1 ER - TY - JOUR AU - Collaboration, P. r. o. s. p. e. c. t. i. v. e. S. t. u. d. i. e. s. AU - Lewington, S. AU - Whitlock, G. AU - Clarke, R. AU - Sherliker, P. AU - Emberson, J. PY - 2007 DA - 2007// TI - Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61778-4 DO - 10.1016/S0140-6736(07)61778-4 ID - Collaboration2007 ER - TY - JOUR AU - Law, M. R. AU - Wald, N. J. PY - 1994 DA - 1994// TI - An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990 JO - Eur J Clin Nutr VL - 48 ID - Law1994 ER - TY - JOUR AU - Schöttker, B. AU - Rathmann, W. AU - Herder, C. AU - Thorand, B. AU - Wilsgaard, T. AU - Njølstad, I. PY - 2016 DA - 2016// TI - HbA1c levels in non-diabetic older adults—no J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders in a meta-analysis of individual participant data from six cohort studies JO - BMC Med VL - 14 UR - https://doi.org/10.1186/s12916-016-0570-1 DO - 10.1186/s12916-016-0570-1 ID - Schöttker2016 ER - TY - JOUR PY - 2005 DA - 2005// TI - Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa052187 DO - 10.1056/NEJMoa052187 ID - ref5 ER - TY - JOUR AU - Stratton, I. M. AU - Adler, A. I. AU - Neil, H. A. AU - Matthews, D. R. AU - Manley, S. E. AU - Cull, C. A. PY - 2000 DA - 2000// TI - Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.405 DO - 10.1136/bmj.321.7258.405 ID - Stratton2000 ER - TY - JOUR AU - Taylor, F. AU - Huffman, M. D. AU - Macedo, A. F. AU - Moore, T. H. AU - Burke, M. AU - Davey Smith, G. PY - 2013 DA - 2013// TI - Statins for the primary prevention of cardiovascular disease JO - Cochrane Database Syst Rev VL - 1 ID - Taylor2013 ER - TY - JOUR AU - Gutierrez, J. AU - Ramirez, G. AU - Rundek, T. AU - Sacco, R. L. PY - 2012 DA - 2012// TI - Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis JO - Arch Intern Med VL - 172 UR - https://doi.org/10.1001/archinternmed.2012.2145 DO - 10.1001/archinternmed.2012.2145 ID - Gutierrez2012 ER - TY - JOUR AU - Karpov, Y. AU - Khomitskaya, Y. PY - 2015 DA - 2015// TI - PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia JO - Cardiovasc Diabetol VL - 25 UR - https://doi.org/10.1186/s12933-015-0268-2 DO - 10.1186/s12933-015-0268-2 ID - Karpov2015 ER - TY - STD TI - Boytsov SA, Khomitskaya Y; on behalf of the CEPHEUS study group. Centralised Survey on the Undertreatment of the Hypercholesterolemia in Russia (CEPHEUS). Кapдиoвacкyляpнaя тepaпия и пpoфилaктикa [Cardiovasc Ther Prev]. 2013;12:4–11. ID - ref10 ER - TY - JOUR AU - Graham, I. AU - Atar, D. AU - Borch-Johnsen, K. AU - Boysen, G. AU - Burell, G. AU - Cifkova, R. PY - 2007 DA - 2007// TI - European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) JO - Eur Heart J VL - 28 UR - https://doi.org/10.1093/eurheartj/ehm316 DO - 10.1093/eurheartj/ehm316 ID - Graham2007 ER - TY - STD TI - Кyxapчyк [Kukharchuk] BB. Диaгнocтикa и кoppeкция нapyшeний липиднoгo oбмeнa c цeлью пpoфилaктики и лeчeния aтepocклepoзa [Diagnosis and correction of lipid metabolism, with a view to the prevention and treatment of atherosclerosis]. Mocквa [Moscow]; 2007. p. 18. ID - ref12 ER - TY - JOUR AU - Perk, J. AU - Backer, G. AU - Gohlke, H. AU - Graham, I. AU - Reiner, Z. AU - Verschuren, M. PY - 2012 DA - 2012// TI - European guidelines on cardiovascular disease prevention in clinical practice (version 2012).The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) JO - Eur Heart J VL - 2012 ID - Perk2012 ER - TY - STD TI - Кyxapчyк [Kukharchuk] BB, Cyceкoв [Susekov] AB, Зyбapeвa MЮ [Zubareva MJ], Гopнякoвa H.Б [Gornyakova NB]. Диaгнocтикa и кoppeкция нapyшeний липиднoгo oбмeнa c цeлью пpoфилaктики и лeчeния aтepocклepoзa [Diagnosis and correction of lipid metabolism, with a view to the prevention and treatment of atherosclerosis]. Кapдиoвacкyляpнaя тepaпия и пpoфилaктикa [Cardiovascular Therapy and Prevention]. 2009;8(6 [Suppl 3]). ID - ref14 ER - TY - JOUR PY - 2012 DA - 2012// TI - Diagnosis and correction of lipid metabolism, with a view to the prevention and treatment of atherosclerosis Russian recommendations. Review V JO - Atheroscler Dyslipidaemia VL - 4 ID - ref15 ER - TY - JOUR AU - Chiang, C. E. AU - Ferrières, J. AU - Gotcheva, N. N. AU - Raal, F. J. AU - Shehab, A. AU - Sung, J. PY - 2016 DA - 2016// TI - Suboptimal control of lipid levels: results from 29 countries participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS) JO - J Atheroscler Thromb VL - 23 UR - https://doi.org/10.5551/jat.31179 DO - 10.5551/jat.31179 ID - Chiang2016 ER - TY - JOUR AU - Levey, A. S. AU - Stevens, L. A. AU - Schmid, C. H. AU - Zhang, Y. L. AU - Castro, A. F. AU - Feldman, H. I. PY - 2009 DA - 2009// TI - A new equation to estimate glomerular filtration rate JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-9-200905050-00006 DO - 10.7326/0003-4819-150-9-200905050-00006 ID - Levey2009 ER - TY - JOUR AU - Stone, N. J. AU - Robinson, J. G. AU - Lichtenstein, A. H. AU - Bairey Merz, C. N. AU - Blum, C. B. AU - Eckel, R. H. PY - 2014 DA - 2014// TI - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines JO - Circulation VL - 129 UR - https://doi.org/10.1161/01.cir.0000437738.63853.7a DO - 10.1161/01.cir.0000437738.63853.7a ID - Stone2014 ER - TY - JOUR AU - Halcox, J. P. AU - Tubach, F. AU - Lopez-Garcia, E. AU - Backer, G. AU - Borghi, C. AU - Dallongeville, J. PY - 2015 DA - 2015// TI - Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0115270 DO - 10.1371/journal.pone.0115270 ID - Halcox2015 ER - TY - JOUR AU - Reiner, Ž. AU - Backer, G. AU - Fras, Z. AU - Kotseva, K. AU - Tokgözoglu, L. AU - Wood, D. PY - 2016 DA - 2016// TI - Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries—findings from the EUROASPIRE IV survey JO - Atherosclerosis. VL - 246 UR - https://doi.org/10.1016/j.atherosclerosis.2016.01.018 DO - 10.1016/j.atherosclerosis.2016.01.018 ID - Reiner2016 ER - TY - JOUR AU - Pogosova, N. V. AU - Oganov, R. G. AU - Boytsov, S. A. AU - Ausheva, A. K. AU - Sokolova, O. J. AU - Kursakov, A. A. PY - 2015 DA - 2015// TI - Monitoring the secondary prevention of coronary artery disease in Europe and Russia: results of the Russian part of the international multicenter study EUROASPIRE IV JO - Kardiologiia VL - 55 UR - https://doi.org/10.18565/cardio.2015.12.99-107 DO - 10.18565/cardio.2015.12.99-107 ID - Pogosova2015 ER - TY - JOUR AU - Hermans, M. P. AU - Castro Cabezas, M. AU - Strandberg, T. AU - Ferrières, J. AU - Feely, J. AU - Elisaf, M. PY - 2010 DA - 2010// TI - Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903500565 DO - 10.1185/03007990903500565 ID - Hermans2010 ER - TY - JOUR AU - Stark Casagrande, S. AU - Fradkin, J. E. AU - Saydah, S. H. AU - Rust, K. F. AU - Cowie, C. C. PY - 2013 DA - 2013// TI - The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010 JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc12-2258 DO - 10.2337/dc12-2258 ID - Stark Casagrande2013 ER - TY - STD TI - International Diabetes Federation (IDF). IDF diabetes atlas, 7th edn. http://www.diabetesatlas.org. Accessed 22 Jul 2017. UR - http://www.diabetesatlas.org ID - ref24 ER - TY - JOUR AU - Rosenblit, P. D. PY - 2016 DA - 2016// TI - Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile? JO - Cardiovasc Diabetol. VL - 15 UR - https://doi.org/10.1186/s12933-016-0412-7 DO - 10.1186/s12933-016-0412-7 ID - Rosenblit2016 ER - TY - JOUR AU - Toth, P. P. AU - Zarotsky, V. AU - Sullivan, J. M. AU - Laitinen, D. PY - 2009 DA - 2009// TI - Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis JO - Cardiovasc Diabetol. VL - 8 UR - https://doi.org/10.1186/1475-2840-8-26 DO - 10.1186/1475-2840-8-26 ID - Toth2009 ER - TY - JOUR AU - Pagidipati, N. J. AU - Navar, A. M. AU - Mulder, H. AU - Sniderman, A. D. AU - Peterson, E. D. AU - Pencina, M. J. PY - 2017 DA - 2017// TI - Comparison of recommended eligibility for primary prevention statin therapy based on the US Preventive Services Task Force recommendations vs the ACC/AHA guidelines JO - JAMA VL - 317 UR - https://doi.org/10.1001/jama.2017.3416 DO - 10.1001/jama.2017.3416 ID - Pagidipati2017 ER - TY - JOUR AU - Mortensen, M. B. AU - Kulenovic, I. AU - Falk, E. PY - 2016 DA - 2016// TI - Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0400-y DO - 10.1186/s12933-016-0400-y ID - Mortensen2016 ER - TY - JOUR AU - Bohn, B. AU - Schöfl, C. AU - Zimmer, V. AU - Hummel, M. AU - Heise, N. AU - Siegel, E. PY - 2016 DA - 2016// TI - Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0391-8 DO - 10.1186/s12933-016-0391-8 ID - Bohn2016 ER - TY - JOUR AU - Masmiquel, L. AU - Leiter, L. A. AU - Vidal, J. AU - Bain, S. AU - Petrie, J. AU - Franek, E. PY - 2016 DA - 2016// TI - LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0341-5 DO - 10.1186/s12933-016-0341-5 ID - Masmiquel2016 ER - TY - JOUR AU - Hanefeld, M. AU - Traylor, L. AU - Gao, L. AU - Landgraf, W. PY - 2017 DA - 2017// TI - The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL JO - Cardiovasc Diabetol VL - 16 UR - https://doi.org/10.1186/s12933-017-0548-0 DO - 10.1186/s12933-017-0548-0 ID - Hanefeld2017 ER - TY - JOUR AU - Wong, N. D. AU - Young, D. AU - Zhao, Y. AU - Nguyen, H. AU - Caballes, J. AU - Khan, I. PY - 2016 DA - 2016// TI - Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012 JO - J Clin Lipidol VL - 10 UR - https://doi.org/10.1016/j.jacl.2016.06.011 DO - 10.1016/j.jacl.2016.06.011 ID - Wong2016 ER - TY - JOUR AU - Gaudet, D. AU - Drouin-Chartier, J. P. AU - Couture, P. PY - 2017 DA - 2017// TI - Lipid metabolism and emerging targets for lipid-lowering therapy JO - Can J Cardiol VL - 33 UR - https://doi.org/10.1016/j.cjca.2016.12.019 DO - 10.1016/j.cjca.2016.12.019 ID - Gaudet2017 ER - TY - JOUR AU - Khomitskaya, Y. U. AU - Logunova, N. A. AU - Boytsov, S. A. PY - 2017 DA - 2017// TI - Positive and negative predictors of LDL-C goals achievement in patients at moderate to very high cardiovascular risk on lipid-lowering drug therapy (CEPHEUS II) JO - Eur J Prev Cardiol VL - 24 ID - Khomitskaya2017 ER - TY - JOUR AU - Logunova, N. A. AU - Gurina, N. AU - Boytsov, S. A. PY - 2017 DA - 2017// TI - Achievement of LDL-C goals in patients at moderate to very high cardiovascular risk on lipid-lowering drug therapy (CEPHEUS II) JO - Atherosclerosis VL - 263 UR - https://doi.org/10.1016/j.atherosclerosis.2017.06.770 DO - 10.1016/j.atherosclerosis.2017.06.770 ID - Logunova2017 ER -